← Back to headlines
Spyre Therapeutics Stock Surges After $10.5 Million Buy
Spyre Therapeutics stock has seen a significant surge over the past year, with a recent $10.5 million buy increasing a stake to $78 million.
23 Feb, 15:38 — 23 Feb, 15:38
Sources
Showing 1 of 1 sources
Related Stories
Treasury Secretary Bessent's Bond Strategy Faces Scrutiny and Criticism
7h ago
Analysts Assess NVIDIA's Valuation and Volatility Risks Following Weekly Stock Decline
10h ago
Richtech Robotics Announces Stock Repurchase Program, Shares Rise
11h ago
Apollo, KKR, and IFM Investors Finalists in AB Ports Stake Sale
11h ago